SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fortis Healthcare trades jubilantly on completing acquisition of 51% stake in Fortis Hospotel

17 Oct 2016 Evaluate

Fortis Healthcare is currently trading at Rs. 182.65, up by 12.30 points or 7.22% from its previous closing of Rs. 170.35 on the BSE.

The scrip opened at Rs. 178.00 and has touched a high and low of Rs. 188.25 and Rs. 176.50 respectively. So far 445790 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 199.00 on 16-Aug-2016 and a 52 week low of Rs. 141.10 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 188.25 and Rs. 166.55 respectively. The current market cap of the company is Rs. 8511.54 crore.

The promoters holding in the company stood at 70.28%, while institutions and non-institutions held 18.56% and 11.16% respectively.

Fortis Healthcare has completed the acquisition of 51% stake in Fortis Hospotel and also acquired compulsorily convertible preference shares issued by Escort Heart Institute and Research Centre.

Earlier in February 4, 2016, the company engaged in healthcare facilities business had said that its board approved the acquisition of 51% economic interest in Fortis Hospotel, a subsidiary of the Religare Health Trust (RHT), by way of acquiring compulsorily convertible debentures from Fortis Global Healthcare Infrastructure.

It had also said that it was contemplating “acquiring compulsorily convertible preference shares issued by Escort Heart Institute and Research Centre, by one of its wholly-owned subsidiary, Fortis Hospitals.

Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning 9 countries.

Fortis Healthcare Share Price

889.75 15.45 (1.77%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×